Advertisement

Topics

DGAP-News: EVOTEC INVESTIERT IN EXSCIENTIA - BESCHLEUNIGUNG DER WIRKSTOFFFORSCHUNG MIT KÜNSTLICHER INTELLIGENZ (AI) (deutsch)

01:30 EDT 28 Sep 2017 | FinanzNachrichten
Related Biotechnology, Pharmaceutical and Healthcare News

EVOTEC INVESTIERT IN EXSCIENTIA - BESCHLEUNIGUNG DER WIRKSTOFFFORSCHUNG MIT KÜNSTLICHER INTELLIGENZ (AI) DGAP-News: Evotec AG / Schlagwort(e): Sonstiges EVOTEC INVESTIERT IN EXSCIENTIA - BESCHLEUN...

Original Article: DGAP-News: EVOTEC INVESTIERT IN EXSCIENTIA - BESCHLEUNIGUNG DER WIRKSTOFFFORSCHUNG MIT KÜNSTLICHER INTELLIGENZ (AI) (deutsch)

NEXT ARTICLE

More From BioPortfolio on "DGAP-News: EVOTEC INVESTIERT IN EXSCIENTIA - BESCHLEUNIGUNG DER WIRKSTOFFFORSCHUNG MIT KÜNSTLICHER INTELLIGENZ (AI) (deutsch)"

Give dad the gift of knowledge. Order his DNA Ancestry kit this Father's Day for $99 at 23andMe! Ord

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
 

News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches


BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2017 BioPortfolio Limited. Site developed by Alacrify Ltd.